Late-Breaking Clinical Trials Session Presents Practice-Changing Data
Current practice guidelines typically recommend discontinuing oral anticoagulation with warfarin for patients undergoing cardiac procedures, but two studies from Thursday’s Late-Breaking Clinical Trials session suggest that patients may do better if warfarin therapy is continued.
Discontinuation of oral warfarin carries a 13-fold risk for periprocedural stroke and hemorrhagic complications following ablation for atrial fibrillation.
“There is an ominous association between atrial fibrillation, ablation and periprocedural stroke,” said Luigi Di Biase, MD, PhD, FHRS, St. David’s Texas Cardiac Arrhythmia Institute, Austin, Texas.
Today’s History Special Session Remembers Arrhythmia Pioneer
Gordon K. Moe, MD, PhD, and His Laboratory Have a Lasting Impact on Cardiac Electrophysiology
A History Special Session honoring Gordon K. Moe, MD, PhD, takes place at 12:15 – 1:15 p.m. today in Room 201.
Dr. Moe was the Director of Research of the Masonic Medical Research Laboratory from 1960-1984. He was involved in the birth of modern cardiac electrophysiology and is best known for his studies on the mechanisms of cardiac arrhythmias, particularly atrial fibrillation.
Explore Innovative Abstracts in the EPicenter — being presented toFriday thru 5 PM at HRS 2013.
Stem Cell-Based Cardiac Resynchronization
Satsuki Yamada, MD, PhD
Quantitative Magnetic Resonance Imaging Analysis of the Relationship between Contact Force and Left Atrial Scar Formation after Catheter Ablation of Atrial Fibrillation
Christian Sohns, MD
Real-Time Positional Adjustment of Electroanatomical Models to Improve Spatial Perception and Catheter Localization
Steven Williams, MRCP
Low Entropy in the Sub-endocardial Scar Can Localize Ventricular Tachycardia Supporting Channels in Post-Infarct Ventricles
Sachin Nayyar, MD
A Novel Strategy for Mapping in Sinus Rhythm to Localize Ventricular Tachycardia Channels in Ischemic Cardiomyopathy
Sachin Nayyar, MD
Development of a Biomarker Panel to Predict Cardiac Resynchronization Therapy Response: Results from the SMART-AV Trial
Francis Spinale, MD, PhD
Evaluation of the Fetal QT Interval Using Non-invasive Fetal ECG Technology
Alisa Niksch, MD
Mutations in a Neuronal Sodium Channel Responsible for a Large Fraction of Brugada Syndrome Cases
Dan Hu, MD, PhD
U-wave on ECG is Associated with Sudden Cardiac Death in General Population
Larisa Tereshchenko, MD, PhD
“We have recently created a new abstract category to showcase the latest innovative studies in the field of heart rhythm management. Novel devices, treatment strategies, gene evaluation and imaging techniques will all be showcased in these unique abstract sessions. This is a great opportunity to take a glimpse into the future of EP and see what the next big thing might just be.”
— John Day, MD, FHRS, Abstract Chair, Scientific Sessions Program Committee
Source: tristarpub.com; May 10, 2013.